MSC-EV Characterization Q&A: CD73, Downstream Processing, & Scalable Manufacturing Answered April 01, 2026 Bioprocessing, Exosomes / Extracellular Vesicles
Get Your Ducks in a Row for GMP Cell Manufacture November 05, 2025 Biomanufacturing, Bioprocessing, Cell Therapy
Balancing the Scale from the Cellular Bank August 06, 2025 Biomanufacturing, Bioprocessing, Cell Therapy
When Data Blooms: Insights into MSC-EV Bioprocessing May 19, 2025 Bioprocessing, Exosomes / Extracellular Vesicles
To 10X & Beyond, AgentV™-DSP Arrives Ready to Rock February 27, 2025 Biomanufacturing, Bioprocessing, Exosomes / Extracellular Vesicles
Analytics: A Referee for the Tug-of-War Between MSC-EVs’ Nature & Nurture December 20, 2024 Bioprocessing, Exosomes / Extracellular Vesicles
AgentV’s Virtues at the Vanguard of Extracellular Vesicles July 31, 2024 BioEconomy, Biomanufacturing, Bioprocessing, Exosomes / Extracellular Vesicles
Leaving Flatland Behind – A View from Experience in 3D Adherent Cell Culture for Advanced Therapies June 18, 2024 Biomanufacturing, Bioprocessing
Countdown to Zero: Overcoming Downstream Processing’s Top Five Challenges for Viral Vectors &… March 12, 2024 BioEconomy, Bioprocessing, Exosomes / Extracellular Vesicles
